11:17:59 EDT Mon 23 Apr 2018
Enter Symbol
or Name
USA
CA



Z:VRX - Valeant Pharmaceuticals International, I - http://www.valeant.com11:17:59 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
VRX - Z0.617.59 · 17.601.117.59+0.412.41,975.534,3996,17917.20  17.6652  17.1424.43  8.310910:57:59Apr 1915 min RT 2¢

Recent Trades - Last 10 of 6179
Time ETExPriceChangeVolume
10:58:07Z17.590.4125
10:58:05Z17.590.41100
10:58:05Z17.590.41100
10:58:05Z17.590.41100
10:58:05Z17.590.41200
10:58:05Z17.590.41100
10:57:59Z17.590.41100
10:57:59Z17.590.41100
10:57:59Z17.590.41100
10:57:59Z17.590.41300

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2018-04-19 08:00U:VRXNews ReleaseBausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program
2018-04-12 16:15U:VRXNews ReleaseValeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due 2020
2018-04-12 14:51U:VRXNews ReleaseArbitral Tribunal Decides In Favor Of Valeant In UCERIS Arbitration
2018-04-11 08:00U:VRXNews ReleaseBausch + Lomb to Showcase New Scientific Data During the Annual Meeting of the American Society of Cataract and Refractive Surgery
2018-04-10 19:33U:VRXNews ReleaseValeant And One Of Its Subsidiaries Announce Expiration And Final Settlement Date For Cash Tender Offers For Senior Notes
2018-04-09 07:45U:VRXNews ReleaseNew Research Coverage Highlights SINOPEC Shangai Petrochemical, Aurinia Pharmaceuticals, Valeant Pharmaceuticals International, NTT DOCOMO, Southern Missouri, and KNOT Offshore Partners LP — Consolidated Revenues, Company Growth, and Expectations for 201
2018-04-09 07:00U:VRXNews ReleaseOrtho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII™ In The Journal of the American Academy of Dermatology
2018-04-09 07:00U:VRXNews ReleaseOrtho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII ™ In The Journal of the American Academy of Dermatology
2018-04-06 08:30U:VRXNews ReleaseEyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis
2018-04-06 08:00U:VRXNews ReleaseValeant Will Release First-Quarter 2018 Financial Results On May 8